Key result
Vagal nerve blockade with atropine in hypoxic healthy volunteers deteriorated pulmonary oxygenation, decreasing PaO2 (P<0.05) and SpO2 (P<0.01) and increasing anatomical and alveolar dead space.
Why the study?
Does vagal nerve blockade with atropine impair pulmonary gas exchange efficiency in healthy hypoxic humans?
Does vagal nerve blockade with atropine impair pulmonary gas exchange efficiency in healthy hypoxic humans?
Vagal nerve blockade with atropine impairs pulmonary gas exchange in hypoxic humans, suggesting that both phasic cardiac and tonic pulmonary vagal nerve activity contribute to gas exchange efficiency.
May support vagal modulation of hypoxic gas exchange; leaves open relevance to patients with lung disease.
The aim of this study was to test our hypothesis that both phasic cardiac vagal activity and tonic pulmonary vagal activity, estimated as respiratory sinus arrhythmia (RSA) and anatomical dead space volume, respectively, contribute to improve the efficiency of pulmonary gas exchange in humans. We examined the effect of blocking vagal nerve activity with atropine on pulmonary gas exchange. Ten healthy volunteers inhaled hypoxic gas with constant tidal volume and respiratory frequency through a respiratory circuit with a respiratory analyser. Arterial partial pressure of O(2) (P(aO(2))) and arterial oxygen saturation (S(pO(2))) were measured, and alveolar-to-arterial P(O(2)) difference (D(A-aO(2))) was calculated. Anatomical dead space (V(D,an)), alveolar dead space (V(D,alv)) and the ratio of physiological dead space to tidal volume (V(D,phys)/V(T)) were measured. Electrocardiogram was recorded, and the amplitude of R-R interval variability in the high-frequency component (RRIHF) was utilized as an index of RSA magnitude. These parameters of pulmonary function were measured before and after administration of atropine (0.02 mg kg(-1)). Decreased RRIHF (P < 0.01) was accompanied by decreases in P(aO(2)) and S(pO(2)) (P < 0.05 and P < 0.01, respectively) and an increase in D(A-aO(2)) (P < 0.05). Anatomical dead space, V(D,alv) and V(D,phys)/V(T) increased (P < 0.01, P < 0.05 and P < 0.01, respectively) after atropine administration. The blockade of the vagal nerve with atropine resulted in an increase in V(D,an) and V(D,alv) and a deterioration of pulmonary oxygenation, accompanied by attenuation of RSA. Our findings suggest that both phasic cardiac and tonic pulmonary vagal nerve activity contribute to improve the efficiency of pulmonary gas exchange in hypoxic conscious humans.
No takes yet. Share an insight, caveat, or question.
Ito et al. (2006) studied Healthy volunteers (n=10). Atropine vs. Before administration (baseline) was evaluated on Pulmonary gas exchange parameters including PaO2, SpO2, and alveolar-to-arterial PO2 difference (p=<0.05). Vagal nerve blockade with atropine in hypoxic healthy volunteers deteriorated pulmonary oxygenation, decreasing PaO2 (P<0.05) and SpO2 (P<0.01) and increasing anatomical and alveolar dead space.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: